Research & Clinical Trials
Mesothelioma Clinical Trials Resume After COVID-19 Disruption
- by Sean Marchese
- Research & Clinical Trials
- Aug 10, 2020
When the COVID-19 pandemic struck earlier this year, clinical trials at medical centers around the world slowed enrollment or placed trial activities on hold. As businesses begin to reopen…
Read More
Mesothelioma T-Cell Therapy Shows Early Effectiveness in Trial
- by Tim Povtak
- Research & Clinical Trials
- Aug 4, 2020
A mesothelioma clinical trial involving genetically modified T cells has opened to considerable acclaim, shrinking tumors in the first five patients who were treated. The phase I portion of the…
Read More
Study Shows Peritoneal Mesothelioma Surgery Underutilized
- by Tim Povtak
- Research & Clinical Trials
- Jul 28, 2020
The continued underutilization of aggressive surgery for peritoneal mesothelioma is shortening survival time dramatically for patients who could qualify for, and benefit from, the highly effective procedure. Only a…
Read More
Merck, Targovax Team Up for New Mesothelioma Clinical Trial
- by Tim Povtak
- Research & Clinical Trials
- Jul 22, 2020
Standard-of-care treatment for malignant mesothelioma could change significantly, depending upon the results of an upcoming clinical trial of two immunotherapy agents used in combination with chemotherapy. The mesothelioma…
Read More
NCI Studying New Mesothelioma Immunotherapy Combination
- by Tim Povtak
- Research & Clinical Trials
- Jul 8, 2020
Patients with mesothelioma are being recruited by the National Cancer Institute for a phase II clinical trial using a novel immunotoxin prior to pembrolizumab, a combination that has…
Read More
Cryoablation Study for Mesothelioma Opening at UCLA
- by Tim Povtak
- Research & Clinical Trials
- Jul 1, 2020
Researchers at UCLA Jonsson Comprehensive Cancer Center will soon begin studying the pre-surgery use of cryoablation as a potential early adjuvant therapy for patients with pleural mesothelioma. The…
Read More
Tazemetostat Shows Promise for Pleural Mesothelioma
- by Tim Povtak
- Research & Clinical Trials
- Jun 24, 2020
Five different research groups at the American Society of Clinical Oncology annual meeting last month made presentations on the effectiveness of tazemetostat, a novel protein inhibitor, in fighting various cancers.
Read More
Mesothelioma Chemoperfusion Trial Shows Impressive Results
- by Tim Povtak
- Research & Clinical Trials
- Jun 22, 2020
Study statistics show the benefits of the novel transarterial chemoperfusion treatment being used successfully at the Moffitt Cancer Center in Tampa for patients with relapsed pleural mesothelioma. Russell Lamkins…
Read More
Study Finds Mesothelioma Therapies Underutilized in Women
- by Tim Povtak
- Research & Clinical Trials
- Jun 15, 2020
A multicenter research team of specialists has uncovered a surprising underutilization of treatments for pleural mesothelioma cancer in women. Clinical Lung Cancer recently published the findings, which showed a…
Read More
Ramucirumab Shows Promise in Mesothelioma Clinical Trial
- by Tim Povtak
- Research & Clinical Trials
- Jun 9, 2020
Patients with pleural mesothelioma cancer experienced a significant survival advantage when ramucirumab, a novel immunotherapy drug, was added to chemotherapy in a treatment regimen. Ramucirumab, marketed by…
Read More
